adenosine diphosphate has been researched along with fulvestrant in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Custódio, J; Moreira, PI; Moreno, A; Oliveira, CR; Santos, MS | 1 |
Massheimer, V; Mendiberri, J; Polini, N; Rauschemberger, MB; Selles, J | 1 |
Blackmore, PF; Chatterjie, N; Dobrydneva, Y; Fichandler, CE; Fitzgerald, MC; Morrell, MM; Trebley, JP; Weatherman, RV | 1 |
3 other study(ies) available for adenosine diphosphate and fulvestrant
Article | Year |
---|---|
Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure.
Topics: Adenosine Diphosphate; Animals; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Electron Transport; Electron Transport Complex I; Estradiol; Flavins; Fulvestrant; Hydrogen Peroxide; Male; Membrane Potentials; Mitochondria; Mitochondria, Liver; Models, Biological; Nucleotides; Oxygen; Oxygen Consumption; Phosphorylation; Rats; Rats, Wistar; Rotenone; Selective Estrogen Receptor Modulators; Submitochondrial Particles; Tamoxifen; Time Factors; Ubiquinone | 2006 |
Effect of genistein and raloxifene on vascular dependent platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Antineoplastic Agents; Aorta; Eicosanoids; Estradiol; Female; Fulvestrant; Genistein; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ovariectomy; Platelet Aggregation; Platelet Aggregation Inhibitors; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators | 2007 |
Tamoxifen stimulates calcium entry into human platelets.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Calcium; Calcium Signaling; Diethylstilbestrol; Drug Synergism; Estradiol; Estrenes; Estrogen Antagonists; Ethamoxytriphetol; Female; Fulvestrant; Humans; Male; Middle Aged; Molecular Structure; Phosphodiesterase Inhibitors; Pyrrolidinones; Stilbenes; Structure-Activity Relationship; Tamoxifen; Thrombin; Vasopressins | 2007 |